Philippe Eggimann1, Didier Pittet. 1. Adult Critical Care Medicine and Burn Unit, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, philippe.eggimann@chuv.ch.
Abstract
INTRODUCTION: For decades, clinicians dealing with immunocompromised and critically ill patients have perceived a link between Candida colonization and subsequent infection. However, the pathophysiological progression from colonization to infection was clearly established only through the formal description of the colonization index (CI) in critically ill patients. Unfortunately, the literature reflects intense confusion about the pathophysiology of invasive candidiasis and specific associated risk factors. METHODS: We review the contribution of the CI in the field of Candida infection and its development in the 20 years following its original description in 1994. The development of the CI enabled an improved understanding of the pathogenesis of invasive candidiasis and the use of targeted empirical antifungal therapy in subgroups of patients at increased risk for infection. RESULTS: The recognition of specific characteristics among underlying conditions, such as neutropenia, solid organ transplantation, and surgical and nonsurgical critical illness, has enabled the description of distinct epidemiological patterns in the development of invasive candidiasis. CONCLUSIONS: Despite its limited bedside practicality and before confirmation of potentially more accurate predictors, such as specific biomarkers, the CI remains an important way to characterize the dynamics of colonization, which increases early in patients who develop invasive candidiasis.
INTRODUCTION: For decades, clinicians dealing with immunocompromised and critically illpatients have perceived a link between Candida colonization and subsequent infection. However, the pathophysiological progression from colonization to infection was clearly established only through the formal description of the colonization index (CI) in critically illpatients. Unfortunately, the literature reflects intense confusion about the pathophysiology of invasive candidiasis and specific associated risk factors. METHODS: We review the contribution of the CI in the field of Candida infection and its development in the 20 years following its original description in 1994. The development of the CI enabled an improved understanding of the pathogenesis of invasive candidiasis and the use of targeted empirical antifungal therapy in subgroups of patients at increased risk for infection. RESULTS: The recognition of specific characteristics among underlying conditions, such as neutropenia, solid organ transplantation, and surgical and nonsurgical critical illness, has enabled the description of distinct epidemiological patterns in the development of invasive candidiasis. CONCLUSIONS: Despite its limited bedside practicality and before confirmation of potentially more accurate predictors, such as specific biomarkers, the CI remains an important way to characterize the dynamics of colonization, which increases early in patients who develop invasive candidiasis.
Authors: Marek Pacholczyk; Beata Lagiewska; Wojciech Lisik; Dariusz Wasiak; Andrzej Chmura Journal: Ann Transplant Date: 2011 Jul-Sep Impact factor: 1.530
Authors: O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann Journal: Clin Microbiol Infect Date: 2012-12 Impact factor: 8.067
Authors: F Marco; S R Lockhart; M A Pfaller; C Pujol; M S Rangel-Frausto; T Wiblin; H M Blumberg; J E Edwards; W Jarvis; L Saiman; J E Patterson; M G Rinaldi; R P Wenzel; D R Soll Journal: J Clin Microbiol Date: 1999-09 Impact factor: 5.948
Authors: Pierre Emmanuel Charles; Jean Marc Doise; Jean Pierre Quenot; Hervé Aube; Frédéric Dalle; Pascal Chavanet; Nadine Milesi; Ludwig Serge Aho; Henri Portier; Bernard Blettery Journal: Intensive Care Med Date: 2003-09-10 Impact factor: 17.440
Authors: Cristóbal León; Sergio Ruiz-Santana; Pedro Saavedra; Beatriz Galván; Armando Blanco; Carmen Castro; Carina Balasini; Aránzazu Utande-Vázquez; Francisco J González de Molina; Miguel A Blasco-Navalproto; Maria J López; Pierre Emmanuel Charles; Estrella Martín; María Adela Hernández-Viera Journal: Crit Care Med Date: 2009-05 Impact factor: 7.598
Authors: Alison M Hall; Lee A L Poole; Bryan Renton; Alexa Wozniak; Michael Fisher; Timothy Neal; Christopher M Halloran; Trevor Cox; Peter A Hampshire Journal: Crit Care Date: 2013-03-18 Impact factor: 9.097
Authors: Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr Journal: Infect Immun Date: 2016-09-19 Impact factor: 3.441
Authors: Francesco Giuseppe De Rosa; Silvia Corcione; Giorgia Montrucchio; Luca Brazzi; Giovanni Di Perri Journal: Turk J Anaesthesiol Reanim Date: 2016-12-01
Authors: P Montravers; S Blot; G Dimopoulos; C Eckmann; P Eggimann; X Guirao; J A Paiva; G Sganga; J De Waele Journal: Intensive Care Med Date: 2016-03-16 Impact factor: 17.440
Authors: Katie Wang; Kevin Hsueh; Ryan Kronen; Charlotte Lin; Ana S Salazar; William G Powderly; Andrej Spec Journal: Mycoses Date: 2019-05-22 Impact factor: 4.377